Hostname: page-component-6766d58669-88psn Total loading time: 0 Render date: 2026-05-20T19:46:49.555Z Has data issue: false hasContentIssue false
  • English
  • Français

Broad spectrum antifungal agents in otomycosis

Published online by Cambridge University Press:  29 June 2007

A. Bassiouny ,
T. Kamel ,
M. K. Moawad  and
D. S. Hindawy
A. Bassiouny
Affiliation:
Otolaryngology Department, Cairo Faculty of Medicine, Consultant Fakhry Hospital, Alkhobar, Saudi Arabia.
T. Kamel*
Affiliation:
Otolaryngology Department, Cairo Faculty of Medicine, Consultant Fakhry Hospital, Alkhobar, Saudi Arabia.
M. K. Moawad
Affiliation:
National Organization for Drug Control and Research, Cairo, Alkhobar, Saudi Arabia.
D. S. Hindawy
Affiliation:
Clinical Pathology Department, Cancer Instiute, Cairo University, Consultant Fakhry Hospital, Alkhobar, Saudi Arabia.
*
Tarek Kamel M.D., Fakhry Hospital, P.O. Box: 251, Alkhobar, Saudi Arabia.
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Research Article
Information
The Journal of Laryngology & Otology , Volume 100 , Issue 8 , August 1986 , pp. 867 - 873
Copyright
Copyright © JLO (1984) Limited 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Abdel Aal, H., and Moawad, M. K. (1973) Clinical experience with canesten cream (Bay b 5097) against Dermatophytes in Egypt. Mykosen. 16: 369–371.Google Scholar
Ajello, L., George, L. K., Kaplan, W., and Kaufman, L. (1966) Laboratory manual for Medical Mycology, Washington DC. Communicable Diseases Center, Public Health Service Publication, US Department of Health Education and Welfare, Government Printing Office, E-7. E-ll, G-46.Google Scholar
Barnett, H. L., and Hunter, B. B. (1972) Illustrated genera of imperfect fungi. Minneapolis, Minnesota, Burgress Publishing Co. U.S.A.Google Scholar
Bassiouny, A., Maker, A., Bucci, T. J., Moawad, M. K., and Hindawy, D. S. (1982) Non invasive antromycosis—Diagnosis and treatment. Journal of Laryngology and Otology, 96: 215–228.CrossRefGoogle ScholarPubMed
Bear, V. D. (1969) Otitis externa: immediate and long term results with flumethasone pivalate/iodochlorhydroxyquine ear drops. Medical Journal of Australia, 1; 273–276.CrossRefGoogle ScholarPubMed
Booth, C. (1971) The genus fusarium. Kew. Surrey, England, Commonwealth Mycological Institute.Google Scholar
Damato, P. J. (1966) Treatment of otomycosis due to Aspergillus niger with tolnaftate. St. Luke's Hospital Gazette. 1: 66–88.Google Scholar
Elbaz, P. (1978) Etude de L‘efficacite’ et de la tolerance du Pevaryl lait 1 per cent dans le triatment de mycoses due conduit auditif externe. Annates d'Oto-Laryngo/ogie (France), 95: 315–320.Google Scholar
Gilman, J. C. (1959) A manual of Soil Fungi. Ames, Iowa. The Iowa State University Press.Google Scholar
Grfgson, A. E. W., and La Touche, C. J. (1961) The significance of mycotic infection in the etiology of otitis externa. Journal of Laryngology and Otology, 75: 167–170.CrossRefGoogle Scholar
Lawrence, T. L., Ayers, L. W., and Saunders, W. H. (1978) Drug therapy in otomycosis: an in vitro study. laryngoscope, 88: 1755–1760.Google Scholar
Lopez, L., and Evens, R. P. (1980) Drug therapv of Aspergillus otitis externa. Otolaryngology, Head and Neck Surgery. 88: 649–651.Google Scholar
Maher, A., Bassiouny, A., Moawad, M. K., and Hindawy, D. S. (1982) Otomycosis: An experimental evaluation of six antimycotic agents. Journal of Laryngology and Otology, 96: 205–213.Google Scholar
Meuner, A., Blassin, R., and Meunier, F. (1975) Remarquable efficacite due Tolnaftate sur les otomycoses (30 observations). Annates d'Oto-Laryngologie (France), 92: 699–702.Google Scholar
Plempel, M., and Bartmann, K. (1972) Experimental studies on the antimycotic action of Clotrimazole (Canesten) in vitro and after local applicaton in vivo. Drugs Made in Germany, 15: 103–120.Google Scholar
Schneider, M. L. (1981) Merthiolate in treatment of otomycosis. Laryngoscope, 91: 1194–1195.Google Scholar
Schoneback, J., and Zakrisson, J. E. (1974) Topical 5-fluorocvtosine therapy in otomycosis. Journal of Laryngology and Otology, 88: 227–231.Google Scholar
Sood, V. P., Sinha, A., and Mohapatra, L. N. (1967) Otomycosis: A clinical entity: clinical and experimental study. Journal of Laryngology and Otology, 81: 999.CrossRefGoogle ScholarPubMed
Than, K. M., Naing, K. S., and Min, M. (1980) Otomycosis in Burma and its treatment. American Journal of Tropical Medicine and Hygiene, 29: 620–623.Google Scholar
Weinstein, M. J., Oden, E. M., and Moss, E. (1964) Antifungal properties of Tolnaftate in vitro and in vivo. Antimicrobial Agents and Chemotherapy, pp. 505–601.Google Scholar
Yamaglchi, H., Hiratani, T., and Ptempei, M. (1983) In vitro studies of a new oral azole antimycotic, BAY N 7133. Journal of Antimicrobial Chemotherapy, 11: 135–149.Google Scholar